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1. Introduction 
PM2 bacteriophage has been demonstrated to pos- 
sess a membrane like structure as an outer coat [7] 
composed of lipids and proteins. The two major phos- 
pholipids species are the same as those present in the 
host Pseudomonas BAL-3 1 [4] , although they display 
quite different proportions [ 1 ] . Furthermore, it has 
been demonstrated that purified PM2 is 60% neutral- 
ized by antibody prepared against purified BAL3 1 
membranes [8] , suggesting a structural similarity 
between the phage outer coat and the cytoplasmic 
membrane of its host. 
The DNA of PM2 approximately codes for 10 pro- 
teins. The mature virus contains 4 proteins which 
would leave about six non-structural proteins to par- 
ticipate in viral formation. This means that host com- 
ponents are likely to be responsible for some steps in 
the process. 
A ribonucleic acid (RNA) polymerase has been 
detected in purified PM2 [3] but it is not known 
whether this protein is virus-specific. One approach to 
this problem is to study if the bacteriophage uses the 
cell polymerase or synthesizes a new one or a sub-unit 
of it after infection. It is known [9] that the anti- 
biotic rifampicin is bound to the beta sub-unit of RNA 
polymerase in Escherichia coli, thus preventing the 
enzyme from initiating RNA biosynthesis. Consequent- 
ly, this drug could be a useful tool to distinguish be- 
tween host and a possible phage induced polymerase 
with a different sensitivity. Therefore, experiments 
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with rifampicin added at different times, before and 
after PM2 infection were done. 
2. Materials and methods 
Pseudomonas BAL3 1 was grown in minimal medi- 
um at 28°C [6] . Rifampicin Lepetit was kindly sup- 
plied by the Instituto Bacteriologico de Chile. For the 
studies of phage production in the presence and ab- 
sence of the antibiotic, cultures with a cell density of 
lo8 cells/ml were used and aliquots distributed in dif- 
ferent flasks. At time zero the cells were infected with 
PM2 at a multiplicity of infection (m.0.i.) of 10; phage 
was allowed to adsorb for 15 min and anti-PM2 serum 
was added, immediately diluted 1 O3 times; a sample 
from each flask was taken, assayed for infective cen- 
tres and plated in rich medium plates. The concentra- 
tion of rifampicin was readjusted to the original con- 
centration and the incubation continued for 150 min. 
Aliquots from each of the flasks were then assayed 
for phage production as usual. 
The [3 Hluracil incorporation experiments were 
done with actively growing cells in minimal medium, 
having a cell density of 10’ cells/ml. Aliquots of 1 ml 
were distributed in test tubes. When required 0.3 pg/ 
ml of rifampicin was added 15 min prior to infection 
and PM2 added at time zero at a multiplicity of 10. 
Thirty min after infection 0.06 /_&i of [3 H] uracil 
were added to all incubation mixtures; 10 min later 
the incorporation was stopped with 1 ml of 10% cold 
trichloroacetic acid (TCA). Samples were filtered on 
Whatman fiberglass paper, dried and counted in 
toluene-fluor in a liquid scintillation counter. 
Aminoacids incorporation was performed with 
actively growing cells. When required the cells were 
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infected at time zero with PM2 at a m.o.i. of IO. At 
different times post infection 1 ml from each culture 
was taken and 0.06 FCi of C3 HIamino acids mixture 
was added. Incorporation was stopped after 5 min by 
the addition of 1 ml of 10% cold TCA containing 
2 mg/ml of casamino acids. The precipitates were 
collected on ‘millipore’ filters, washed 10 times with 
5% cold TCA containing 2 mg/ml of casamino acids, 
dried and the remaining radioactivity was determined 
in toluene-fluor in a liquid scintillation counter. 
3. Results and discussion 
In order to select the concentration of rifampicin 
to be used in the experiments, rich medium plates [4] 
were prepared with different antibiotic concentrations. 
An actively growing culture was spread on the agar 
plates and incubated at 28°C for two days. Poor 
growth was observed in the presence of 0.30 pg/ml of 
rifampicin. Concentrations between 0.5 and 30 pug/ml 
of the drug were tested and none of them allowed 
Pseudomonas to grow under these same conditions. 
Fig.1 shows the sensitivity of BAL-31 to 0.3 pg/ml of 
rifampicin as a function of time. 
1 ig. 1. At time zero two aliquots of actively growing Ps. BAL- 
31 in minimal medium were placed in separate flasks, 0.3 MS/ 
ml of rifampicin was added to one of them. Aliquots were 
taken for viable counts at the indicated times and plated in 
rich medium. ‘J untreated cells, l rifampicin treated cells. 
Table 1 
PM2 formation in the presence of rifampicin 
Time of Infective Free Burst 
rifampicin centres mature virus size 
addition* pfu/ml X 10.’ pfu/ml X 10m7 
(min) 
-30 0.25 0.53 2 
0 2.5 3.0 1.2 
+15 3.2 70 22 
+30 2.5 160 64 
+60 1.9 320 168 
2.6 900 346 
* 0.3 fig/ml of rifampicin was added before or after infection 
at the indicated times. The sign ~ stands for time before 
infection and + for time after infection. Details of the experi- 
ment are given in the text. 
The effect of rifampicin on PM2 development was 
subsequently studied by the addition of 0.3 pg/ml of 
the drug at different times before or after infection. 
Table 1 shows that Pseudomonas are not capable of 
forming mature phage when the antibiotic is added 
before or at the time of infection. Late addition allows 
the bacteria to produce mature PM2, but consistently 
less phage is produced than in cultures without rifamp- 
icin. 
It was interesting to investigate how RNA synthesis 
was affected by the presence of rifampicin. Table 2 
shows that at 30 min post-infection, RNA synthesis 
in infected cells treated with the antibiotic was 
decreased to a fifth of that in untreated infected cells, 
although in uninfected cells the RNA synthesis only 
Table 2 
Effect of rifampicin on RNA synthesis 
Incubation medium [ 3 HI-uracil incorporation 
cpm/ml 
1’s. BAL-3 I 
PC. HA L-3 1 + rifampicin 
Ps. BAL-31 + PM2 
Ps. BAL-31 + PM2 + 
rifampicin 
2256 
1272 
2056 
420 
When necessary 0.3 fig/ml of rifampicin was added I5 min 
before infection. At time zero the bacteria were infected 
and 30 min post-infection the labelled tracer was added. The 
experiment is described in the text. 
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3’0 6b 90 120 150 
minutes after infection 
Fig.2. Aliquots of an actively growing Pseudonomas culture 
were placed in separate flasks; at the indicated times 0.3 pg/ 
ml of rifampicin was added. Incorporation of aminoacids 
was done as described in Materials and methods. A normal 
cells, A cells + rifampicin added at time zero, o infected cells, 
l cells treated with rifampicin 15 min before infection and 
e cells treated with rifampicin 20 min after infection. 
diminished to a half of that obtained in the control 
cells. It is important to point out here that after 
rifampicin treatment, incorporation of [3 Hluracil by 
infected cells is about one third that of rifampicin 
treated uninfected cells. This result suggests that at 
30 min post-infection there is a net viral RNA syn- 
thesis, which is more sensitive to the drug than the 
host RNA synthesis. 
To study the effect of rifampicin on protein syn- 
thesis, experiments on incorporation of 3 H-labelled 
aminoacids in uninfected and infected cells were 
carried out. Fig.2 shows that when rifampicin is added 
to actively growing Pseudomonas, 15 min before infec- 
tion, protein synthesis 30 min post infection has been 
decreased to a third of that in untreated infected cells. 
This suggests that under these conditions the antibio- 
tic affects viral protein synthesis more than protein 
synthesis in uninfected cells. These results are compa- 
rable with the data presented for RNA synthesis. Pro- 
tein synthesis at 120 min post-infection, when almost 
60% of the total mature virus has been made in this 
minimal medium, is decreased to 10% of that in untreat- 
ed infected cells if rifampicin has been added 15 min 
prior to infection. If the drug is added 20 min post- 
infection a 20-fold decrease in protein synthesis occurs, 
showing that at this time there is present a polymerase 
sensitive to the drug. These results correlate well with 
those presented in Table 1, since the production of 
mature phage is affected by the antibiotic when this 
is added even 60 min after infection. 
From the results presented here it is concluded 
that for the formation of mature PM2 phage, an intact 
polymerase system is needed from the beginning of 
infection. Up to now it has not been known whether 
this is of bacterial or viral origin. 
It has been reported but not confirmed that puri- 
fied PM2 possess a RNA polymerase activity [3], 
from the experiments just described it would seem 
reasonable to assume that the enzyme suggested as 
present in mature phage is not capable of transcribing 
the necessary information for the synthesis of the 
phage in the presence of rifampicin. It is also possible 
that the phage utilizes the host polymerase which has 
been demonstrated here to be very sensitive to 
rifampicin. Furthermore, these results show unequivo- 
cally that, during PM2 replication there is no synthesis 
of a rifampicin-resistant polymerase as occurs in 
bacteriophage T7 [IO] . 
The data just presented are compatible with the 
idea that bacteriophage PM2 uses the host polymerase 
early in infection and that probably later in infection 
a viral-coded polymerase, with a greater sensitivity to 
inhibition by rifampicin than the host polymerase is 
responsible for the phage maturation. 
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